We are live on ! Find out more
Viking Global Investors

Viking Global Investors Portfolio holdings

AUM $35.7B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
-4.78%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$36.5B
AUM Growth
+$3.48B
Cap. Flow
+$5.21B
Cap. Flow %
14.28%
Top 10 Hldgs %
38.65%
Holding
113
New
25
Increased
26
Reduced
33
Closed
17

Top Buys

Rank Stock Value
1
DNA icon
Ginkgo Bioworks
DNA
+$4.13B
2
HUM icon
Humana
HUM
+$1.03B
3
PH icon
Parker-Hannifin
PH
+$724M
4
MCD icon
McDonald's
MCD
+$714M
5
BN icon
Brookfield
BN
+$696M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$936M
2
AON icon
Aon
AON
+$693M
3
PANW icon
Palo Alto Networks
PANW
+$576M
4
NOW icon
ServiceNow
NOW
+$559M
5
TMO icon
Thermo Fisher Scientific
TMO
+$455M

Sector Composition

Rank Sector Weight
1 Healthcare 38.33%
2 Technology 18.92%
3 Industrials 11.99%
4 Consumer Discretionary 11.25%
5 Financials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTM
51
ZoomInfo Technologies
GTM
$1.19B
$236M 0.65%
3,859,159
+1,477,885
+62% +$88.4M
CP icon
52
Canadian Pacific Kansas City
CP
$80.8B
$224M 0.62%
+3,447,633
New +$246M
THC icon
53
Tenet Healthcare
THC
$20.9B
$223M 0.61%
3,353,856
+1,074,674
+47% +$76.2M
LH icon
54
Labcorp
LH
$26.1B
$223M 0.61%
921,592
-677,062
-42% -$171M
MTCH icon
55
Match Group
MTCH
$8.45B
$214M 0.59%
1,365,007
-991,399
-42% -$151M
PRCT icon
56
Procept Biorobotics
PRCT
$1.31B
$187M 0.51%
+4,907,892
New +$188M
IR icon
57
Ingersoll Rand
IR
$33B
$184M 0.5%
3,641,009
-2,776,245
-43% -$141M
INBX
58
DELISTED
Inhibrx, Inc. Common Stock
INBX
$177M 0.48%
5,305,866
– –
MRSH
59
Marsh
MRSH
$91.3B
$175M 0.48%
1,156,185
-901,276
-44% -$136M
NTLA icon
60
Intellia Therapeutics
NTLA
$1.68B
$172M 0.47%
1,279,531
+304,439
+31% +$46.1M
CTLT
61
DELISTED
CATALENT, INC.
CTLT
$155M 0.42%
1,163,034
+44,569
+4% +$5.57M
RPRX icon
62
Royalty Pharma
RPRX
$25.7B
$150M 0.41%
4,140,508
+901,854
+28% +$35M
ZNTL icon
63
Zentalis Pharmaceuticals
ZNTL
$295M
$141M 0.39%
2,118,284
-281,000
-12% -$16.2M
ACHC icon
64
Acadia Healthcare
ACHC
$2.9B
$134M 0.37%
2,102,758
+42,633
+2% +$2.69M
HDB icon
65
HDFC Bank
HDB
$120B
$123M 0.34%
+3,358,260
New +$125M
PVH icon
66
PVH
PVH
$3.91B
$119M 0.33%
1,161,695
+522,221
+82% +$56.2M
KRTX
67
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$106M 0.29%
868,696
+46,231
+6% +$5.34M
FDMT icon
68
4D Molecular Therapeutics
FDMT
$600M
$106M 0.29%
3,937,914
– –
TMO icon
69
Thermo Fisher Scientific
TMO
$224B
$104M 0.29%
182,237
-829,164
-82% -$455M
AHCO icon
70
AdaptHealth
AHCO
$754M
$94.9M 0.26%
4,074,029
+977,601
+32% +$23.6M
ALGN icon
71
Align Technology
ALGN
$12.3B
$74.2M 0.2%
111,570
-292,517
-72% -$199M
OLPX
72
DELISTED
Olaplex Holdings
OLPX
$74M 0.2%
+3,022,372
New +$74M
RLYB icon
73
Rallybio
RLYB
$87M
$73.7M 0.2%
+524,347
New +$61.5M
CRL icon
74
Charles River Laboratories
CRL
$13.5B
$73.2M 0.2%
177,403
-174,465
-50% -$72.5M
ILMN icon
75
Illumina
ILMN
$29.1B
$63M 0.17%
+159,668
New +$73.4M
1 2
3
4 5

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Viking Global Investors's Q3 2021 Portfolio in Review

As of Q3 2021, Viking Global Investors held 113 positions worth $36.5B, up 11% from $33B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Viking Global Investors deployed $5.21B of net new capital in Q3 2021, opening 25 new positions and adding to 26 existing holdings. Its largest new stake was Ginkgo Bioworks: 8,476,379 shares worth $3.93B.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Amazon, an estimated $936M trimmed.

  • Viking Global Investors's largest Q3 2021 buy was Ginkgo Bioworks: 8,476,379 shares worth $3.93B.
  • Viking Global Investors added most to Humana in Q3 2021, an estimated $1.03B increase.
  • Viking Global Investors's biggest Q3 2021 reduction was Amazon, cutting an estimated $936M.
  • Viking Global Investors fully exited Aon in Q3 2021, selling an estimated $693M.
  • Viking Global Investors's ten largest holdings make up 39% of its $36.5B portfolio in Q3 2021.
  • Viking Global Investors opened 25 new positions and closed 17 in Q3 2021.
  • Viking Global Investors's portfolio value rose 11% quarter-over-quarter to $36.5B.

Based on Viking Global Investors's 13F filing for Q3 2021, filed 15 Nov 2021.